Transforming care through purposeful action
EVERY organisation has its own unique journey, shaped by vision, people and progress.
Novo Nordisk's journey in Malaysia began in 1992 with a modest setup and a vision to make a meaningful difference. As a Danish pharmaceutical company, Novo Nordisk has grown its local presence into a workforce of 159 employees and an expansive network of partnerships and initiatives focused on transforming chronic disease care.
Today, the company has invested nearly RM40mil locally in clinical research and patient access efforts, positioning itself not only as a pharmaceutical company, but as a responsible contributor and trusted partner to Malaysia's healthcare ecosystem.
The recent opening of its refurbished Malaysian office reflects this enduring commitment to addressing the burden of chronic diseases in the country.
Employees of Novo Nordisk Malaysia together with the Danish Ambassador to Malaysia Kirstine Vangkilde Berner (centre, in blue), Jay (back row, middle) and Novo Nordisk corporate vice president (Business Area South-East Asia) Anand Shetty, at the reopening of the company's office in Kuala Lumpur.
'We are opening the refurbished office to reinforce our commitment to managing chronic diseases in Malaysia,' said Novo Nordisk senior vice president for the Asia Pacific (APAC) region Jay Thyagarajan during an interview at Menara 1 Sentrum in Kuala Lumpur.
Novo Nordisk's mission is especially timely as Malaysia faces a growing public health challenge. According to the National Health and Morbidity Survey 2023, 1 in 6 adults in Malaysia is living with diabetes and 2 in 5 of them are unaware of their condition. Furthermore, 2.5% of Malaysian adults live with four non-communicable diseases (NCDs): diabetes, obesity, hypertension and high cholesterol.
In response, Novo Nordisk is strengthening its role in Malaysia through various patient-centric initiatives, strategic partnerships, digital innovation and community education — all aimed at improving early intervention, access to care and sustainable disease management.
'We've made the office a purpose-driven workplace where every employee walks in wanting to make a difference,' Jay shared. 'Our goal is to create an environment that truly enables that change. It's about fostering a more inclusive and purpose-driven culture.'
A key feature of the new office design is its openness. Private offices and hierarchical barriers have been removed. Now, everyone — from directors to general managers — shares the same collaborative space.
'Everybody sits out in the open, which encourages faster decision-making, closer collaboration and a sense of shared responsibility,' Jay explained.
This setup also plays a vital role in talent development.
'When you're confined to a room, you don't get to see everyone in action. But when you're working side by side with your colleagues, you witness their strengths firsthand. It helps us identify key talent and shape clear career growth opportunities.'
He added that this environment has contributed significantly to the company being recognised as one of the Best Places to Work in Malaysia for the past three years.
'We've been able to attract some of the best talent in the healthcare industry. The challenge is no longer about attracting talent — it's about continuously developing those employees and nurturing the career progression they are keen to pursue,' Jay noted.
'At Novo Nordisk, we have a strong global network that actively supports career progression. Many of our colleagues participate in global talent programmes, leadership exchanges and development courses across regions and countries. These initiatives open doors to more job opportunities for those committed to strengthening their performance."
Jay, who began his journey as a sales representative and has worked in over 10 countries throughout his 28-year career, is living proof of this commitment.
Innovative hub
A major pillar of Novo Nordisk Malaysia's innovation drive is its Clinical Development Centre (CDC), established in 2024. It is the only multi-country CDC in South-East Asia, supporting clinical research not just in Malaysia, but also in Singapore and Thailand.
'CDC Malaysia is not just a local hub — it's a regional engine for clinical innovation,' said Jay. 'We've conducted more than 24 clinical trials across diabetes, obesity, cardiovascular disease and liver conditions in just the last five years. That's backed by an investment of nearly RM40mil and it's set to increase in the coming years.'
The CDC currently supports over 100 clinical trial sites, with 56 dedicated staff driving trials across multiple therapy areas, including Metabolic Dysfunction-Associated Steatohepatitis (MASH).
CDC Malaysia signed a Memorandum of Understanding with Clinical Research Malaysia on May 9, last year to strengthen the strategic partnerships between both parties, in the presence of Health Minister Datuk Seri Dr Dzulkefly Ahmad.
In 2024 alone, it contributed to 32 clinical trials, engaging more than 825 patients and earning the prestigious IO-CDC Award for 2nd Best Multi-Country CDC.
Beyond research, the CDC plays a transformative role in shaping Malaysia's clinical trial ecosystem — training investigators, building site capacity and accelerating patient access to innovative treatments.
Compassionate care
Another cornerstone of Novo Nordisk Malaysia's impact is its Changing Diabetes in Children (CDiC) programme, launched locally in 2023. This global initiative aims to ensure that no child with type 1 diabetes (T1D) is left untreated.
'Adults can often manage, but children with diabetes need a different kind of support – educational, medical and emotional. This is a holistic approach to create the right awareness for those children and their parents and to ensure they receive proper education to manage the disease.'
Among others, Jay explained that the programme involves capacity building for healthcare professionals, establishing and refurbishing diabetes resource centres in hospitals and maintaining a robust national T1D registry to improve outcomes through data-driven care.
Driven by local implementation partner Malaysia Endocrine and Metabolic Society (MEMS) with support from the Health Ministry, Higher Education Ministry and Novo Nordisk global partners, CDiC supports patients through the provision of glucose monitoring tools, alongside education and awareness initiatives to support children and their families.
'The goal is to treat at least 3,000 patients by 2028 and we are making good progress toward achieving that.'
'For us, enabling healthcare through digital tools is an ongoing effort,' said Jay.
Digital access
Novo Nordisk Malaysia recognises that managing chronic diseases requires more than just medication — it demands an ecosystem of care, supported by digital health tools.
'We are thinking about the entire patient journey,' said Jay. 'From awareness and education to diagnosis, treatment and long-term management, digital health plays a key role in creating convenience and better outcomes.'
Among its many digital initiatives is the HCP Locator — a digital tool that helps patients identify the right doctors for obesity.
Novo Nordisk also collaborates with telehealth providers, pharmacies and media partners to improve disease literacy and expand access to support services.
'For us, enabling healthcare through digital tools is an ongoing effort,' said Jay. 'We work closely with the Health Ministry to prevent misuse or misinformation that could impact patients, because we take chronic disease management very seriously.'
'These efforts aim to reduce the social and economic burden of chronic diseases — which in Malaysia account for nearly 68% of deaths and consume close to 4.5% of the country's GDP.'
Sustainable healthcare
Novo Nordisk Malaysia's long-term vision is anchored in three pillars: access, innovation and sustainability. The company is focused on building an ecosystem of care that integrates education, prevention and sustainable practices.
'We form many partnerships with our stakeholders to build an ecosystem for managing chronic diseases. This includes creating disease awareness, establishing treatment protocols and driving prevention activities,' said Jay.
Among these partnerships are:
>The Jom Mama Project (2013–2018): A collaboration with the Health Ministry (MOH) and academic institutions to promote pre-pregnancy health and reduce the risk of gestational and Type 2 diabetes risk. The initiative resulted in numerous academic publications, shared key learnings with MOH departments during stakeholder forums and conducted capacity building for community nurses at district health clinics in Seremban;
>The ERAT programme: Conceptualised in 2024 and currently in development, this programme collaborates with MOH pharmacists to help patients manage Type 2 diabetes better through structured HCP education and regular blood glucose monitoring;
>The Green Transition Alliance (2025–ongoing): Established with the Royal Danish Embassy, this initiative supports Malaysia's green agenda and promotes green collaboration between Denmark and Malaysia covering focus areas of healthy urban living, renewable energy, energy efficiency and water and environment.
Novo Nordisk Malaysia's local environmental commitments include supporting MOH to promote responsible disposal of unused medication in the MyMediSafe programme to avoid contaminating the environment, especially river sources. Disposal bins are made available throughout various participating clinics, hospitals and retail pharmacies for the public to dispose of their unwanted medicines. Novo Nordisk Malaysia has also developed an internal environmental management plan in its office to reduce plastic use, embed sustainability criteria in procurement and sourcing of vendors, reduce carbon dioxide (CO2) with travel caps and promote virtual meetings and organise external green activities.
The company also partners with local medical associations, including the Malaysian Obesity Society, for policy advocacy and capacity-building initiatives.
'We believe access to quality healthcare should be a right, not a privilege. We want to be part of a healthier future, where innovative therapies and sustainable practices go hand in hand,' Jay added.
Through these initiatives, Novo Nordisk not only supports Malaysia's healthcare goals but also aligns with its global purpose: to drive change for serious chronic diseases and the people affected by them.
To learn more about the company and its initiatives, visit Novo Nordisk Malaysia.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
2 hours ago
- The Sun
Duopharma Biotech secures halal certification for biosimilar anaemia treatment
KUALA LUMPUR: Duopharma Biotech Bhd has achieved another milestone in the halal pharmaceutical sector with the halal certification of a biosimilar product used to treat anaemia in patients with chronic renal failure. The certification, awarded by the Department of Islamic Development Malaysia (JAKIM), strengthens Duopharma's position at the forefront of Malaysia's halal pharmaceutical sector. Group Managing Director Leonard Ariff Abdul Shatar said the product is used in adult and paediatric patients undergoing haemodialysis or the predialysis stage. It is currently supplied to both public and private healthcare facilities nationwide. 'This certification marks a key advancement in the company's biologics journey and will further motivate our efforts to provide consumers and patients with access to medicines and therapies that are assured safe and effective, high in quality, hygienic and halal from the start,' Leonard Ariff said referring to the product which is manufactured at Duopharma's plant in Klang. He added that the certification is timely, given the rising number of dialysis patients in Malaysia. The Ministry of Health projects that over 106,000 Malaysians may require dialysis by 2040, with more than 10,000 new cases annually if current trends persist. Duopharma has been a pioneer in the biologics, having launched Malaysia's first Phase 3 clinical trial for an Epoetin Alfa biosimilar in 2014 with South Korea's Pangen Biotech Inc. In 2018, it became the first Malaysian company to install a biologic pre-filled syringe production line. The company also promotes the halal pharmaceutical agenda globally through the annual Halal Pharmaceuticals Symposium, which it has hosted since 2016, bringing together global experts, regulators and industry leaders to advance halal integration in the healthcare system.
The Sun
2 hours ago
- The Sun
Duopharma Biotech secures halal cert for anaemia treatment
KUALA LUMPUR: Duopharma Biotech Bhd has achieved another milestone in the halal pharmaceutical sector with the halal certification of a biosimilar product used to treat anaemia in patients with chronic renal failure. The certification, awarded by the Department of Islamic Development Malaysia (JAKIM), strengthens Duopharma's position at the forefront of Malaysia's halal pharmaceutical sector. Group Managing Director Leonard Ariff Abdul Shatar said the product is used in adult and paediatric patients undergoing haemodialysis or the predialysis stage. It is currently supplied to both public and private healthcare facilities nationwide. 'This certification marks a key advancement in the company's biologics journey and will further motivate our efforts to provide consumers and patients with access to medicines and therapies that are assured safe and effective, high in quality, hygienic and halal from the start,' Leonard Ariff said referring to the product which is manufactured at Duopharma's plant in Klang. He added that the certification is timely, given the rising number of dialysis patients in Malaysia. The Ministry of Health projects that over 106,000 Malaysians may require dialysis by 2040, with more than 10,000 new cases annually if current trends persist. Duopharma has been a pioneer in the biologics, having launched Malaysia's first Phase 3 clinical trial for an Epoetin Alfa biosimilar in 2014 with South Korea's Pangen Biotech Inc. In 2018, it became the first Malaysian company to install a biologic pre-filled syringe production line. The company also promotes the halal pharmaceutical agenda globally through the annual Halal Pharmaceuticals Symposium, which it has hosted since 2016, bringing together global experts, regulators and industry leaders to advance halal integration in the healthcare system.
The Star
8 hours ago
- The Star
Putting a stop to online child sexual grooming
In recent times, we have witnessed an unsettling surge in cases of child sexual grooming linked to social media platforms. Beneath the glossy facade of influencer culture lies a growing epidemic that preys on children. The Malaysian Mental Health Association believes it is time we recognise this as a national concern. This is not just a digital safety issue; it is a child protection crisis. Social media influencers now wield more power over young minds than teachers or parents. They produce content that is aspirational and intimate. For children and teens, this creates a dangerous illusion of closeness and trust. Just recently, a social media influencer was arrested and remanded for four days to assist in an investigation regarding allegations of sending obscene pictures to a teenage girl. According to Bukit Aman's Sexual, Women and Child Investigation Division, over 30% of all child sexual grooming cases received by police involved social media influencers or public figures. Police say offenders often use their online popularity to build trust with victims before allegedly committing indecent acts. Clearly, the very platforms that gave these individuals reach also gave them unfiltered access to their victims. A need for validation Adolescents are neurologically wired for risk-taking and a desire for novelty. The teenage brain, particularly the prefrontal cortex that is responsible for judgement and impulse control, is still in the process of maturation and development throughout adolescence. Social media's dopamine-driven algorithms lead children to crave validation and social connection at any cost. A 2020 United Nations Children's Fund (Unicef) report indicates that 91% of Malaysian children aged 13 to 17 use the internet daily, including social media, with 70% having been exposed to disturbing content. Another study by Unicef Malaysia in 2021 showed that 4% of children aged 12 to 17 who use the internet face threats of online sexual exploitation and abuse. Children who feel emotionally neglected, face bullying or are socially isolated are particularly vulnerable. To them, the attention of a popular influencer feels like salvation until it turns into control, manipulation or abuse. Potentially-severe consequences The psychological toll of online grooming is overwhelming. Victims of grooming and online sexual exploitation frequently experience persistent sadness, hopelessness and low self-esteem. These may trigger anxiety and panic disorders. In some instances, children may develop post-traumatic stress disorder (PTSD), which is characterised by intrusive memories, nightmares, dissociation and emotional numbing. Many of these symptoms may be invisible to others, but to the victims, they can be immensely disabling. A tragically-common response when shame outweighs coping resources is self-harm and suicidal thoughts. Many victims never disclose what happened and the grooming never comes to light. Victims are afraid to speak up. The influencer may be a highly influential public figure who is widely adored. Victims fear judgement, disbelief, shame, being blamed for 'leading on' the adult and/or retaliation from the influencer, particularly if the influencer is well-known or admired in the community. The 2022 National Health and Morbidity Survey (NHMS) showed that a significant portion of adolescents were affected by mental health concerns. Specifically, one in four adolescents experienced depression symptoms, and 7.9% reported having suicidal thoughts. These findings highlight a concerning trend in adolescent mental health in Malaysia. Though these figures are not all attributable to grooming, online exploitation could be a significant, underreported contributor. Mental health support is also not always accessible. The shortage of clinical psychologists and trauma-informed therapists in Malaysia makes it difficult for survivors to receive timely, appropriate care. While services like Talian Kasih (15999) and Talian HEAL (1-5555) provide some frontline support, there is still a long way to go in making trauma services available, affordable and stigma-free. Legal protection, difficult enforcement Defined as the process of establishing a relationship with a child to sexually exploit them, child grooming is a grave violation of a child's rights and dignity. The Sexual Offences Against Children Act 2017 (Act 792) comprehensively addresses this conduct by criminalising various acts associated with grooming, thereby providing a legal framework to prosecute offenders and protect vulnerable children. However, there are gaps in enforcement and digital oversight. Groomers often operate across jurisdictions, and enforcement agencies struggle to keep pace with encrypted chats, disappearing messages or apps with little data retention. Even when complaints are lodged, investigations can take a considerable amount of time, allowing the influencer to continue posting, gather followers and potentially groom more victims. The influencer ecosystem in Malaysia remains largely unregulated. Vetting influencer behaviour, monitoring content aimed at minors, or penalising misconduct seem wanting. Technology companies operating in Malaysia should enhance their response times to promptly address take-down requests or address child safety concerns. What can we do? Malaysia must rise to this challenge with a united front involving parents, schools, platforms, influencers, civil society and the government. Influencers who produce content for, or feature, children must be subject to professional codes of conduct, background checks and platform-specific moderation. Any breach related to child endangerment must result in swift account suspension and legal action. All Malaysian schools should include age-appropriate modules on digital safety, grooming awareness and online boundaries. This is as essential as any other subject taught in our schools. We must invest in child and adolescent mental health services. The government must encourage trauma-informed training for school counsellors and continue to increase the number of clinical psychologists in the public sector. Subsidised care, such as that offered by the Malaysian Mental Health Association (Helpline 03-2780 6803 or email support@ should also be made available to grooming survivors by other non-governmental bodies. The government should increase public awareness of the excellent service offered by Talian Kasih (15999) and the Cyber999 complaint channel provided by CyberSecurity Malaysia. Reporting mechanisms must be child-friendly and confidential, and followed by immediate support. Social media companies operating in Malaysia must be legally required to implement child protection tools, including AI-based grooming detection and proactive removal of grooming content. Hopefully, this is topmost on the agenda of the Malaysian Communications and Multimedia Commission (MCMC). Influence for good The voice of responsible influencers in Malaysia is crucial. They shape the culture, trends and digital norms of our society. They should utilise their platforms to call out grooming, educate their followers and stand in solidarity with survivors. If influencers feature children in their content, they should also protect them, not just physically, but emotionally and psychologically as well. To the popular influencers out there, we say: 'Your audience includes impressionable young people. 'Influence them toward dignity, respect and empowerment, not harm.' Every child has the right to grow up free from fear and abuse, whether offline or online, and every adult must ensure that right is protected. We can no longer afford to treat grooming as a rare or foreign concept. It is happening here, on Malaysian soil, on Malaysian phones, and often under the guise of 'likes' and 'followers'. There must be accountability for those who exploit their influence. Datuk Dr Andrew Mohanraj is a consultant psychiatrist and the Malaysian Mental Health Association president. For more information, email starhealth@ The information provided is for educational and communication purposes only, and it should not be construed as personal medical advice. The Star does not give any warranty on accuracy, completeness, functionality, usefulness or other assurances as to the content appearing in this column. The Star disclaims all responsibility for any losses, damage to property or personal injury suffered directly or indirectly from reliance on such information.
